Significant responses to platinum-based chemotherapy in renal medullary carcinoma

John J. Strouse, Melissa Spevak, A. Kyle Mack, Robert J. Arceci, Donald Small, David M. Loeb

Research output: Contribution to journalArticlepeer-review

48 Scopus citations


Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel.

Original languageEnglish (US)
Pages (from-to)407-411
Number of pages5
JournalPediatric Blood and Cancer
Issue number4
StatePublished - Apr 2005
Externally publishedYes


  • Chemotherapy
  • Renal medullary carcinoma
  • Sickle cell trait

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology


Dive into the research topics of 'Significant responses to platinum-based chemotherapy in renal medullary carcinoma'. Together they form a unique fingerprint.

Cite this